The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the Met receptor tyrosine kinase

Citation
Cr. Maroun et al., The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the Met receptor tyrosine kinase, MOL CELL B, 20(22), 2000, pp. 8513-8525
Citations number
83
Categorie Soggetti
Molecular Biology & Genetics
Journal title
MOLECULAR AND CELLULAR BIOLOGY
ISSN journal
02707306 → ACNP
Volume
20
Issue
22
Year of publication
2000
Pages
8513 - 8525
Database
ISI
SICI code
0270-7306(200011)20:22<8513:TTPSIR>2.0.ZU;2-B
Abstract
Epithelial morphogenesis is critical during development and wound healing, and alterations in this program contribute to neoplasia. Met, the hepatocyt e growth factor (HGF) receptor, promotes a morphogenic program in epithelia l cell lines in matrix cultures. Previous studies have identified Gab1, the major phosphorylated protein following Met activation, as important for th e morphogenic response. Gab1 is a docking protein that couples the Met rece ptor with multiple signaling proteins, including phosphatidylinositol-3 kin ase, phospholipase C gamma, the adapter protein Crk, and the tyrosine speci fic phosphatase SHP-2. HGF induces sustained phosphorylation of Gab1 and su stained activation of extracellular signal-regulated kinase (Erk) in epithe lial Madin-Darby canine kidney cells. In contrast, epidermal growth factor fails to promote a morphogenic program and induces transient Gab1 phosphory lation and Erk activation. To elucidate the Gab1-dependent signals required for epithelial morphogenesis, we undertook a structure-function approach a nd demonstrate that association of Gab1 with the tyrosine phosphatase SHP-2 is required for sustained Erk activation and for epithelial morphogenesis downstream from the Met receptor. Epithelial cells expressing a Gab1 mutant protein unable to recruit SHP-2 elicit a transient activation of Erk in re sponse to HGF. Moreover, SHP-2 catalytic activity is required, since the ex pression of a catalytically inactive SHP-2 mutant, C/S, abrogates sustained activation of Erk and epithelial morphogenesis by the Met receptor. These data identify SHP-2 as a positive modulator of Erk activity and epithelial morphogenesis downstream from the Met receptor.